AndrewCHarrisMD

Pediatric Hematology & Oncology • New York, NY

Associate Attending - Memorial Sloan Kettering Cancer Center

Overview of Dr. Harris

Dr. Andrew Harris is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Primary Children's Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 12 years. He is one of 51 doctors at Primary Children's Hospital and one of 96 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He has more than 70 publications and over 500 citings.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(231) 680-2289

Education & Training

University of MichiganFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Cleveland Clinic FoundationResidency, Pediatrics, 2005 - 2008
Case Western Reserve University School of MedicineClass of 2005

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2021 - 2026
UT State Medical License 2015 - 2022
MI State Medical License 2008 - 2018
OH State Medical License 2005 - 2008
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...
Neel S Bhatt, Andrew C Harris, Lev Gorfinkel, Katarzyna Ibanez, Eric R Tkaczyk
Transplantation and Cellular Therapy. 2024-12-17
Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic.
Andrew C Harris, Alina Markova, Sean Devlin, Amandeep Singh, Pamela Susman
Transplantation and Cellular Therapy. 2024-12-01
Late-Onset Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation.
Andrew C Harris, Kimia Ganjaei, Camila Vilela, Alexander Geyer
Transplantation and Cellular Therapy. 2024-09-01

Abstracts/Posters

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
Andrew C Harris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Andrew C. Harris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019